YAMANA GOLD INC (AUY)       5.95  +0.09 (+1.54%)

5.95  +0.09 (+1.54%)

CA98462Y1007 - Common Stock - After market: 5.94 -0.01 (-0.17%)


Fundamental Rating

3

Taking everything into account, AUY scores 3 out of 10 in our fundamental rating. AUY was compared to 967 industry peers in the Metals & Mining industry. AUY has a bad profitability rating. Also its financial health evaluation is rather negative. AUY is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

3

AUY has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for AUY.
AUY has a Profit Margin of 14.01%. This is comparable to the industry average of 14.60%.

AUY's Return On Assets of 3.10% is worse than the rest of the industry. The industry average Return On Assets is 7.48%. 82% of the industry peers have a better Return On Assets.
AUY's Return On Equity of 5.91% is worse than the rest of the industry. The industry average Return On Equity is 12.52%.
VS Industry

ROA (3.1%) VS Industry: 18% outperformed.

0.09
231.29

ROE (5.91%) VS Industry: 28% outperformed.

0.10
178.28

Profit Margin (14.01%) VS Industry: 47% outperformed.

0.68
1,966.43

Valuation

Valuation Rating

3

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a Price/Earnings Ratio of 18.03, AUY is valued on the expensive side.
With a Forward Price/Earnings Ratio of 21.88, AUY is valued rather expensively.
When comparing the current price to the book value of AUY, we can conclude it is valued correctly. It is trading at 1.30 times its book value.

Compared to an average industry price book ratio of 1.63, AUY is valued in line with its industry peers.
When comparing the Enterprise Value to EBITDA ratio of AUY to the average industry ratio of 6.23, AUY is valued in line with its industry peers.
AUY's Price/Earning Ratio is slightly more expensive than the industry average, which is at 12.50.
VS Industry

Price/Earnings (18.03) VS Industry: 39% outperformed.

967.00
0.15

Price/Book (1.3) VS Industry: 58% outperformed.

3,418.00
0.03

Enterprise Value/ EBITDA (6.51) VS Industry: 45% outperformed.

374.61
0.07

Growth

Growth Rating

3

Measured over the past 5 years, AUY shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.88% on average per year.
The Earnings Per Share has been growing slightly by 3.13% over the past year.
AUY shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
The Revenue has been growing slightly by 0.31% on average over the past 5 years.

The Revenue is expected to decrease by -2.34% on average over the next 5 years.
The Earnings Per Share is expected to decrease by -36.47% on average over the next 5 years. This is quite bad
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS38.88% 37.21% 3.13% -9.07% -6.34% -4.98% -36.47%
Revenue0.31% 0.31% 4.53% 0.11% -0.08% -0.44% -2.34%

Health

Health Rating

2

The Piotroski-F score of AUY is 7.00. This is a strong score and indicates good health and profitability for AUY.
AUY has a Current Ratio of 1.98. This is a normal value and indicates that AUY is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.52 indicates that AUY should not have too much problems paying its short term obligations.
When comparing the Current Ratio of AUY to the average industry Current Ratio of 2.56, AUY is less able to pay its short term obligations than its industry peers.

When comparing the Quick Ratio of AUY to the average industry Current Ratio of 2.16, AUY is less able to pay its short term obligations than its industry peers.
AUY has one of the worst Debt to Equity ratios in its industry. 84% of its industry peers require less debt for financing their operations.
Based on the Altman-Z score of 0.76, we must say that AUY is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of AUY to the average industry Altman-Z score of 2.50, AUY is less financially healthy than its industry peers.
VS Industry

Debt/Equity (0.18) VS Industry: 16% outperformed.

4.14
0.00

Quick Ratio (1.52) VS Industry: 40% outperformed.

0.00
178.59

Current Ratio (1.98) VS Industry: 40% outperformed.

0.00
178.59

Altman-Z (0.76) VS Industry: 36% outperformed.

-22,403.48
2,354.89

Dividend

Dividend Rating

5

The dividend of AUY is nicely growing with an annual growth rate of 65.10%!
AUY has been paying a dividend for at least 10 years, so it has a reliable track record.
With a Yearly Dividend Yield of 2.04%, AUY has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.10, AUY has a dividend in line with its industry peers.

44.24% of the earnings are spent on dividend by AUY. This is a bit on the high side, but may be sustainable.
AUY's Dividend Yield is slightly below the S&P500 average, which is at 2.60.
The Dividend Rate of AUY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (2.04%) VS Industry: 46% outperformed.

0.27
24.74

YAMANA GOLD INC5.95

NYSE:AUY (3/28/2023, 4:22:55 PM)+0.09 (+1.54%)

After market: 5.94 -0.01 (-0.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-16 2023-02-16
Earnings (Next)04-25 2023-04-25
Inst Owners59.55%
Inst Owner Change-0.02%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.72B
Analysts73.85
Price Target6.44 (8.24%)
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Dividend Growth(5Y)65.1%
DP44.24%
Div Incr Years4
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.47%
Min EPS beat(2)16.48%
Max EPS beat(2)24.45%
EPS beat(4)4
Avg EPS beat(4)21.31%
Min EPS beat(4)7.51%
Max EPS beat(4)36.78%
Revenue beat(2)1
Avg Revenue beat(2)0.36%
Min Revenue beat(2)-2.82%
Max Revenue beat(2)3.55%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)3.55%
PT rev (1m)31.31%
PT rev (3m)41.27%
EPS NQ rev (1m)-1.34%
EPS NQ rev (3m)11.02%
EPS NY rev (1m)2.33%
EPS NY rev (3m)2.33%
Revenue NQ rev (1m)5.6%
Revenue NQ rev (3m)11.75%
Revenue NY rev (1m)1.05%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 18.03
Fwd PE 21.88
P/S 3.08
P/FCF 20.82
P/OCF 7.7
P/B 1.3
P/tB 1.43
EV/EBITDA 6.51
EPS(TTM)0.33
EY5.55%
EPS(NY)0.27
Fwd EY4.57%
FCF(TTM)0.29
FCFY4.8%
OCF(TTM)0.77
OCFY12.98%
SpS1.93
BVpS4.58
TBVpS4.17
PEG (NY)N/A
PEG (5Y)0.46
Profitability
Industry RankSector Rank
ROA 3.1%
ROE 5.91%
ROIC 4.42%
ROICexc 4.75%
ROICexgc 5.01%
OM 24%
PM 14.01%
GM 59.63%
ROICexgc(3y)4.58%
ROICexcg growth 3Y34.53%
ROICexcg growth 5Y28.6%
ROICexc(3y)4.33%
ROICexc growth 3Y34.57%
ROICexc growth 5Y28.76%
OM growth 3Y33.99%
OM growth 5Y25.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.07%
GM growth 5Y7.78%
F-Score7
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.17
Debt/EBITDA 0.96
Cap/Depr 100.3%
Profit Quality 105.78%
Current Ratio 1.98
Quick Ratio 1.52
Altman-Z 0.76
F-Score7
WACC9.69%
ROIC/WACC0.52
Cap/Depr(3y)75.16%
Cap/Depr(5y)93.96%
Profit Quality(3y)165.26%
Profit Quality(5y)N/A
Growth
EPS 1Y3.13%
EPS 3Y37.21%
EPS 5Y38.88%
EPS growth Q2Q-28.57%
EPS Next Y-9.07%
EPS Next 2Y-6.34%
EPS Next 3Y-4.98%
EPS Next 5Y-36.47%
Revenue growth 1Y4.53%
Revenue growth 3Y0.31%
Revenue growth 5Y0.31%
Revenue growth Q2Q-6.59%
Revenue Next Year0.11%
Revenue Next 2Y-0.08%
Revenue Next 3Y-0.44%
Revenue Next 5Y-2.34%
EBIT growth 1Y-12.11%
EBIT growth 3Y34.4%
EBIT growth 5Y26.24%
EBIT Next Year88.11%
EBIT Next 3Y22.5%
EBIT Next 5Y9.59%
FCF growth 1Y-27.06%
FCF growth 3YN/A
FCF growth 5Y16.12%
OCF growth 1Y15.84%
OCF growth 3Y21.83%
OCF growth 5Y2.23%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA